MedPath

OMNISCAN

OMNISCAN

Approved
DIN Number

02172771

Drug Class

Human

Market Date

Mar 25, 1997

Company
HC

ge healthcare canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02172771
AIG Number0126095001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08CA03 GADODIAMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

GADODIAMIDEActive
Strength: 287 MG / ML
Monograph: GADODIAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.